12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Friday's intraday session, several healthcare stocks experienced significant movements. Gainers included Castle Biosciences, Bluejay Diagnostics, T2 Biosystems, SCWorx, Akebia Therapeutics, and Caribou Biosciences. Losers included ASLAN Pharma, Immix Biopharma, BioXcel Therapeutics, Axcella Health, Incannex Healthcare, and Vistagen Therapeutics.
July 07, 2023 | 5:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Akebia Therapeutics stock moved upwards by 20.88% to $1.05.
The significant rise in Akebia Therapeutics' stock price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Bluejay Diagnostics stock moved upwards by 43.53% to $0.31.
The significant rise in Bluejay Diagnostics' stock price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Caribou Biosciences stock increased by 20.7% to $7.17.
The significant rise in Caribou Biosciences' stock price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Castle Biosciences shares rose 54.4% to $20.5.
The significant rise in Castle Biosciences' share price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
T2 Biosystems stock moved upwards by 32.4% to $0.11.
The significant rise in T2 Biosystems' stock price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
SCWorx stock increased by 25.72% to $0.37.
The significant rise in SCWorx's stock price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
ASLAN Pharma shares fell 13.6% to $2.49.
The significant drop in ASLAN Pharma's share price indicates negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Axcella Health shares decreased by 9.1% to $0.2.
The significant drop in Axcella Health's share price indicates negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
BioXcel Therapeutics stock declined by 9.2% to $9.88.
The significant drop in BioXcel Therapeutics' stock price indicates negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Immix Biopharma shares declined by 12.97% to $2.25.
The significant drop in Immix Biopharma's share price indicates negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Incannex Healthcare shares decreased by 9.01% to $1.92.
The significant drop in Incannex Healthcare's share price indicates negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Vistagen Therapeutics shares declined by 8.5% to $1.83.
The significant drop in Vistagen Therapeutics' share price indicates negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100